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Abstract To test the structure of tmRNA in solution, cross-
linking experiments were performed which showed two sets of
cross-links in two different domains of tmRNA. Site-directed
mutagenesis was used to search for tmRNA nucleotide bases that
might form a functional analogue of a codon^anticodon duplex to
be recognized by the ribosomal A-site. We demonstrate that
nucleotide residues U85 and A86 from tmRNA are significant for
tmRNA function and propose that they are involved in formation
of a tmRNA element playing a central role in A-site recognition.
These data are discussed in the frame of a hypothetical model
that suggests a general scheme for the interaction of tmRNA
with the ribosome and explains how it moves through the
ribosome. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: tmRNA; Ribosome; Translation; Cross-linking;
Site-directed mutagenesis
1. Introduction
tmRNA, also known as SsrA RNA, or 10S RNA, is a small
stable RNA which is present in all eubacteria as well as in
some chloroplasts and mitochondria [1,2]. Its 3P- and 5P-ends
are folded into a tRNA-like structure with an amino acid
acceptor stem that possesses identity elements of tRNAAla
and enables speci¢c aminoacylation of the tmRNA by ala-
nyl-tRNA synthetase [3]. tmRNA has a short open reading
frame in the middle of the molecule surrounded by pseudo-
knots (the mRNA module) that encodes a degradation signal
(tag-peptide) for certain cellular proteases [4]. The combina-
tion of properties of both tRNA and mRNA results in an
unusual translational mechanism for this molecule known as
‘trans-translation’ ^ switching the translation from a cellular
mRNA lacking a stop codon to the coding part of tmRNA,
thus adding the tag-peptide to the truncated polypeptide chain
[5,6].
Until recently almost nothing was known about how such a
bulky molecule with very stable secondary and tertiary struc-
ture interacts with the ribosome and how it carries out the
trans-translation process. In this paper we present data for
testing of tmRNA structure by a photoa⁄nity cross-linking
approach. Two sets of cross-links were observed. The ¢rst set
is within the tRNA-part of tmRNA, whereas the second set
represents the connection between U182 and di¡erent nucle-
otide residues in the area of pseudoknots 2 and 3. To reveal
the nucleotides potentially involved in A-site recognition by
the tmRNA, site-directed mutagenesis was applied. The e¡ects
of the mutations were tested in an in vivo system. The muta-
tions in the pre-resume codon are not essential for tmRNA
functioning, but substitution of two neighboring nucleotides
leads to the phenotype of a tmRNA knockout strain. These
data support our hypothesis that describes in general terms
how tmRNA can enter and pass through the ribosome.
2. Materials and methods
2.1. Cross-linking and analysis of cross-linked products
Modi¢ed tmRNA was synthesized by T7 transcription as described
in [7]. After puri¢cation, tmRNA was preincubated for 10 min at
37‡C under the following ionic conditions: 20 mM HEPES^KOH,
pH 7.8 (0‡C), 3 mM MgCl2, 150 mM NH4Cl, 2 mM spermidine,
0.05 mM spermine and 4 mM 2-L-mercaptoethanol. The ¢nal concen-
tration of tmRNA was 1 pmol/Wl. The reaction mixture was irradiated
by mild (s 300 nm) UV light, as described in [8], and cross-linked
products were analyzed by the combination of RNase H and primer
extension techniques, as described in [9,10], in the presence of oligo-
deoxyribonucleotides, as indicated in the legend to Fig. 4.
2.2. Strains, plasmids and phage
Escherichia coli strains were grown in LB-medium or on LB-agar
plates containing 1^1.5% agar/l. Ampicillin and/or chloramphenicol
were added to plates or media as needed. Strains K8619 (ssrA: :cat),
K37 and hybrid phage VimmP22 dis c2-5 were kind gifts from Dr.
David Friedman. To generate the plasmid pGEM-ssrA, the promoter
and coding sequences of the ssrA gene were ampli¢ed by PCR to add
NcoI and SalI sites at the 5P- and 3P-ends, respectively. This DNA was
digested with NcoI and SalI and cloned into NcoI^SalI digested
pGEM (Promega). SsrA mutants were constructed using the Quick-
Change Site-Directed Mutagenesis kit (Stratagene) or PCR splicing by
the overlap extension method [11], and cloned into pGEM using NcoI
and SalI digestion. Mutant sequences were veri¢ed by DNA sequenc-
ing.
2.3. E⁄ciency of plating (EOP)
The EOP of phage VimmP22 dis c2-5 on the wild-type strain K37
and its derivate K8619 with or without mutant plasmids was deter-
mined as described in [12].
2.4. In vitro aminoacylation
Full transcripts of tmRNA were alanylated in 20 mM HEPES^
KOH, pH 7.6 at 0‡C, 10 mM Mg(CH3COO)2, 150 mM NH4Cl, 4
mM L-mercaptoethanol, and 3 mM ATP. 50 pmol of tmRNA and 30
pmol of AlaRS were incubated in the presence of 20 mM [14C]Ala
(speci¢c activity 350 dpm/pmol) in a volume of 30 Wl for 20 min at
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37‡C. The yield of charging was determined by precipitation with cold
trichloroacetic acid.
3. Results and discussion
The central question for understanding the mechanism of
tmRNA function is how does it move through the ribosome.
We propose here a working hypothesis that describes sche-
matically the major steps of tmRNA^ribosome interactions
and tmRNA movement through the ribosome. The results
of our recent experiments performed to check the reliability
of this hypothesis are also presented.
The presence of four pseudoknots in the secondary struc-
ture of E. coli tmRNA (Fig. 1) is well documented [13,14]. It
is hard to imagine that these pseudoknots have to be un-
wound during tmRNA movement through the ribosome
[15]. We propose the existence of two compactly folded do-
mains (containing pseudoknots) in the tmRNA molecule that
interact with speci¢c sites of the ribosome and retain their
contacts with the ribosome during translation of the coding
region of tmRNA. The ¢rst domain (domain 1) is proposed to
be essential for tmRNA entering the ribosome. Thus, it
should contain an alanylated-tRNA region which interacts
with elongation factor (EF)-Tu (and SmpB) on the one
hand and an element that structurally mimics a codon^anti-
codon complex of mRNA with tRNA to be recognized by the
A-site of the ribosome on the other. The remaining elements
of this domain might be necessary to modulate the shape of
the tRNA^mRNA complex in order to ¢t the intersubunit
space of the ribosome and to allow interactions with EF-
Tu^GTP. We assume that this domain contains the tRNA-
like region, helix 2 and pseudoknot 1. Domain 2 might consist
of helix 5 and pseudoknots 2 and 3. It should be mentioned
that in di¡erent organisms the elements of this domain can
vary [16], but spatially they can be folded into a similarly
shaped structure. Additional evidence for two independent
domains in tmRNA is the existence in some organisms of
tmRNA molecules consisting of two pieces (containing do-
mains 1 and 2 correspondingly) [17]. Domains 1 and 2 are
connected with each other by the mRNA module and the
pseudoknot 4. The schematic arrangement of tmRNA is
shown in Fig. 2. Domains 1 and 2 can be close to each other
in solution (Fig. 2A) and form a very compact structure that
might be stabilized by interactions with proteins (e.g. SmpB
[18], S1 [19], EF-Tu [20]). In this structure, the mRNA single-
stranded module should be buried between the two domains.
A compactly folded aminoacylated (aa-)tmRNA enters the
ribosomal A-site in a complex with EF-Tu^GTP [20], which is
probably similar to that formed by a ‘normal’ aa-tRNA [21].
When domain 1 of tmRNA is recognized by the A-site, a
conformational change take place in the ribosome that trig-
gers GTP hydrolysis. This leads to conformational changes in
EF-Tu and possibly also of tmRNA. The alanylated CCA-end
of the tmRNA moves into the peptidyl-transferase center of
the ribosome and the intersubunit space opens to allow EF-
Tu to be released. At this stage domain 2 should occupy its
binding site at the ribosome.
In accordance with the known location of the mRNA chan-
nel [22] the domain 2 binding site should be situated on the
solvent side of the 30S subunit. In this case, the single-
stranded coding region of tmRNA will occupy the channel
in such a way that helices 5a and 5b (see Fig. 1), which
must be unwound in the course of trans-translation, would
be located at or near the hypothetical mRNA helicase [22].
Next, EF-G^GTP interacts with the ribosome to promote
translocation, after which the tRNA-like part of domain 1 as
well as the functional analog of the codon^anticodon duplex
is at the P-site, and the resume codon of tmRNA (shown by
nucleotide residues in Fig. 2B) has entered the A-site due to
opening of the mRNA region. Domain 2 remains at its bind-
ing site on the ribosome. In the next step, domain 1 moves
from the P site into the E site and might leave the decoding
area of the ribosome, still being outside of the L1 ‘mushroom’
(Fig. 2C). Domain 2 remains in the ribosome until termina-
tion takes place (Fig. 2B,C). The mRNA region moves step by
step in the usual way (Fig. 2C). When the stop codon appears
at the A-site, canonical termination occurs and the tmRNA
leaves the ribosome after dissociation of the latter to subunits.
Two experimental approaches were used to test the above
hypothesis.
Photoa⁄nity cross-linking was used to test the structure of
tmRNA in solution. tmRNA with randomly distributed thio-
uridine residues was subjected to mild UV irradiation. Five
cross-linked products were detected (Fig. 3), which were ana-
lyzed with the help of RNase H digestions (Fig. 4A) and in
some cases with primer extension (Fig. 4B), the commonly
used procedures for cross-link site analysis [9,10]. Cross-link
5 is located in the tRNA-region of tmRNA (Fig. 1) and links
U16-17 with the tmRNA sequence 325^345. Cross-links 1^3
all contain U182 from the loop of pseudoknot 2 (Fig. 1),
linked to three di¡erent nucleotides from the region contain-
ing pseudoknots 2 and 3. Cross-link 4 consists of combination
of two cross-linking products: cross-link 5 with one of the
products of 1^3. Neither RNase H nor primer extension
worked during our attempts to determine the partners of
U182, indicating an extremely compact folding of this domain
of the tmRNA that prevents the annealing of oligodeoxyribo-
nucleotides to this region. Thus, the cross-linking data ob-
tained in this work allow us to suggest the existence of two
Fig. 1. Secondary structure of tmRNA with numbered helices and
pseudoknots (taken from http://psysche.uthct.edu/dbs/tmRDB/
tmRDB.html).
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compactly folded domains in the tmRNA molecule, in agree-
ment with the hypothetical scheme of tmRNA tertiary struc-
ture described above (Fig. 2).
Site-directed mutagenesis experiments were performed to
reveal those nucleotides of the tmRNA that participate in
formation of the tmRNA element potentially involved in rec-
ognition by the ribosomal A-site (an element of the domain 1
in the hypothetical model). We assume that this element con-
tains a structure that functionally mimics the codon^antico-
don duplex of a canonical aa-tRNA^mRNA complex to be
recognized by the decoding center of the A-site [23]. The ¢rst
candidate for ‘codon’ in the presumed duplex is the triplet
preceding the resume codon, since after the translocation
event the resume codon enters the ribosomal A-site, allowing
the translational switch to the coding region of tmRNA. The
complementary triplet partner (potential ‘anticodon’) was pro-
posed to be nucleotides 318^320, because this sequence is
complementary to the pre-resume triplet and could be placed
at the anticodon position of the tRNA-like region, this
tmRNA region has been proposed to interact with the decod-
ing site of the ribosome [24]. To test this suggestion, the
tmRNA sequence (87)GUC(89) adjacent to the resume-codon
GCA was replaced by UAC, GAC or GAG. Similarly, the
potential anticodon (318)GAU(320) was changed to GAG or
AAG. A plasmid pGEM-ssrA carrying the gene ssrA (or its
mutants) with its own promoter and terminator was con-
structed for in vivo experiments. The mutants were tested
for tmRNA activity with the help of phage VimmP22 dis c2-
5, since it is known that functional tmRNA is required to
support the growth of this phage [12]. No signi¢cant e¡ects
were detected in any of the mutants (Fig. 5), indicating that
the tmRNA element recognized by the A-site has a more
complicated structure than that of a simple triplet duplex
formed with the help of the pre-resume codon.
The second assumption was that nucleotides (84)AUA(86)
might participate in the formation of a codon^anticodon du-
Fig. 2. A model for tmRNA folding. A, P, E ribosomal sites are marked. Numbering of helices and pseudoknots corresponds Fig. 1. A:
tmRNA in solution; the tRNA-like structure is black, the rest of the molecule is gray. Domains 1 and 2 are marked. B: tmRNA with the re-
sume codon (shown as nucleotides) at the A-site and the tRNA-like structure of domain 1 at the P-site of the ribosome. C: tmRNA after sev-
eral steps of translocation. For more explanation, see text.
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plex analogue in tmRNA. The trinucleotide sequence
(84)AUA(86) is conserved in almost all known tmRNAs
and is located close to the resume codon. Further,
(84)AU(85) might form Watson^Crick pairs with other, very
conserved elements of tmRNA, namely (68)UA(69) or
(300)UA(301). Alternatively, the tmRNA element recognized
by the ribosomal A-site could be a single-stranded codon that
may keep the conformation of the RNA A-form [25]. This
function could be preformed by the pre-resume codon in
tmRNA (J.F. Curran and V.I. Lim, personal communication),
but in this case the neighboring nucleotides, (85)UA(86),
should have a signi¢cant e¡ect on the conformation of this
codon.
Accordingly, we mutated (85)UA(86) to CA, UC, or CC.
Dramatic e¡ects were observed: in the case of CA, the e⁄-
ciency of phage plating was reduced 15 times as compared
with the wild type, whereas in the case of UC and CC, the
EOP was reduced by as much as four orders of magnitude,
similar to the phenotype with a knocked-out tmRNA gene
(Fig. 5). To test whether one of the mutations might a¡ect
the structure of the tRNA part, the level of aminoacylation
was assessed for the lethal mutants. The yield of aminoacyla-
tion was 36% for all the tmRNAs, both mutants and wild
type, suggesting that our mutants have local functional defects
rather than severe e¡ects on the overall structure of domain 1
which is recognized by alanyl-tRNA-synthetase. The results of
our in vivo hybrid phage analysis are also in agreement with
the data reported by Lee at al. [26] where the mutation A86C
seriously damaged the e⁄ciency of trans-translation in an in
vitro system, although this mutant retained the normal bind-
ing capacity to the ribosome. These data indicate that nucle-
otide residues U85 and A86 of tmRNA are signi¢cant for
tmRNA function and may be involved in the formation of
a tmRNA element playing a central role in A-site recognition.
Previously, we have shown that residues U308 (helix 2) and
U268 (pseudoknot 4) outside the tRNA-like part of tmRNA
can form a cross-link with EF-Tu^GDP [7], thus demonstrat-
ing a new binding site of the EF which is quite di¡erent from
the canonical interaction of EF-Tu^GTP with aa-tRNA. On
the basis of the proposed hypothesis, we can speculate about
Fig. 3. Gel electrophoretic analysis of the cross-linked products of
tmRNA, containing one to two thiouridine residues per molecule,
after mild UV irradiation. Lane 1, tmRNA without UV irradiation
(non-cross-linked tmRNA used as a control for further analysis) ;
lane 2, tmRNA after UV-irradiation. X1^X5 ^ cross-linked prod-
ucts.
Fig. 4. Examples of the analyses of the cross-linked products. A: RNase H analysis of cross-linked products 2 and 4 by gel electrophoresis
after digestion of the RNA by RNase H in the presence of pairs of oligodeoxyribonucleotides. Lanes 1^3, without oligodeoxyribonucleotides.
Lanes 4^6, in the presence of an oligodeoxyribonucleotide complementary to the sequence 200^217 of tmRNA. Lanes 7^9, oligodeoxyribonu-
cleotides complementary to 200^217 and 346^363. Lanes 10^12, oligodeoxyribonucleotides complementary to 200^217 and 312^325. Lanes 13^
15, oligodeoxyribonucleotides complementary to 200^217 and 274^291. Lanes 16^18, oligodeoxyribonucleotides complementary to 200^217 and
243^260. Lanes 19^21, oligodeoxyribonucleotides complementary to 200^217 and 128^145. Lanes 22^24, oligodeoxyribonucleotides complemen-
tary to 200^217 and 56^73. Lanes 1, 4, 7, 10, 13, 16, 19, 22, hydrolysis of the control sample (K in Fig. 3). Lanes 2, 5, 8, 11, 14, 17, 20, 23,
hydrolysis of cross-link 2 (X2 in Fig. 3) product. Lanes 3, 6, 9, 12, 15, 18, 21, 24, hydrolysis of cross-link 4 (X4 in Fig. 3) product. The posi-
tions of the cross-links are marked by arrowheads. Numbers at the bands correspond to the length of the fragments. B: Primer extension anal-
ysis of the cross-links. An oligodeoxyribonucleotide complementary to region 274^291 in tmRNA was used as primer. A, G, C, U, sequencing
lanes. Lane K, control sample (from control lane 1 in Fig. 3). Lanes X1^X5, analysis of the cross-linked products (Fig. 3). The position of the
reverse transcriptase stop at position C183, corresponding to the cross-link from U182, is marked by an arrow.
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the functional importance of this unusual complex. (i) The
complex might re£ect the interaction of EF-Tu with ribo-
some-bound tmRNA after GTP hydrolysis. GTP hydrolysis
causes a signi¢cant conformational change in EF-Tu [21],
whereby the EF-Tu domains 2 and 3 move in relation to
domain 1 by up to 40 Aî , and this dramatic conformational
change might be exploited by tmRNA to facilitate the opening
of its structure, according to the proposed model (Fig. 2A,B).
(ii) An alternative explanation is the protection of domain 1
of tmRNA by EF-Tu^GDP, when the tRNA module of the
tmRNA leaves the ribosome during recognition of the third
codon of the mRNA module.
The experimental data presented here are consistent with
the hypothetical scheme proposed in this paper, but clearly
the hypothesis needs more experimental testing.
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Fig. 5. EOP of phage VimmP22 dis c2-5 on K8619 (ssrA: :cat) with
a plasmid carrying di¡erent mutants of tmRNA. K37 (WT) is a
strain with wild-type ssrA.
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